Jan van Den Berghe

Jan Van den Berghe is an accomplished entrepreneur and executive with extensive experience in the biopharmaceutical industry. As a Co-Founder of Novalis_Fund since January 2018, Jan has played a pivotal role in financing innovative ventures. Additionally, Jan serves on the Supervisory Board of Enzyre B.V. and holds board positions at Alithea Genomics, Carroucell, and Trince. Jan directs operations at myNEO Therapeutics and BioLizard while contributing as an Operating Partner at Victus Participations and as a Director at OHMX.bio. Formerly a Co-Founder of Epify BV, Jan holds multiple MBA degrees from INSEAD and Vlerick Business School, complemented by a degree in Bio-engineering from Ghent University.